PIK3CA and colorectal carcinoma: Co-treatment of CRC cells with 5-FU and the PI3K/mTOR inhibitor NVP-BEZ235 induces inhibition of the AKT survival pathway and activation of FOXO3a-mediated transcription of target genes related to cell death [118].